Influencing factors for influenza vaccination among the elderly

Influencing factors for influenza vaccination among the elderly

Objective: To investigate the status and influencing factors of influenza vaccination among the elderly, so as to provide insights into improving the strategies for influenza vaccination among the elderly. Methods: Elderly people aged 60 years and above were recruited from one community each in five...

Full description

Saved in:

Bibliographic Details
Main Author:	LI Yiyao, LI Xiaoju, SHEN Xiaoying, ZHANG Xianqi, ZHAO Li, ZHANG Yuhan, WANG Xinmeng
Format:	Article
Language:	zho
Published:	Editorial Office of China Preventive Medicine Journal 2025-01-01
Series:	预防医学
Subjects:	the elderly influenza vaccine vaccination vaccine literacy influencing factor
Online Access:	http://www.zjyfyxzz.com/CN/10.19485/j.cnki.issn2096-5087.2025.01.007
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Understanding barriers to influenza vaccination among parents is important to improve vaccine uptake among children
by: Stephanie A. Davey, et al.
Published: (2025-12-01)

Effectiveness of inactivated influenza vaccine against laboratory-confirmed influenza in elderly Chinese patients with diabetes: A test-negative design case-control study
by: Zhengyan Chen, et al.
Published: (2025-12-01)

Pneumococcal vaccination in elderly care facilities in Japan: A cross-sectional, web-based survey
by: Youngju Kim, et al.
Published: (2025-12-01)

Evaluating Families’ Opinions of Routine Influenza Vaccination in Children Under 5 Years of Age in Spain
by: Sílvia Burgaya-Subirana, et al.
Published: (2025-01-01)

Vaccine effectiveness against influenza-associated hospitalizations in adults with liver disease, 2015–2020: US Hospitalized Adult Influenza Vaccine Effectiveness Network (HAIVEN)
by: Po-Han Huang, et al.
Published: (2025-12-01)

The Development of a Novel Broad-Spectrum Influenza Polypeptide Vaccine Based on Multi-Epitope Tandem Sequences
by: Song Zhao, et al.
Published: (2025-01-01)

Cross-protection against homo and heterologous influenza viruses via intranasal administration of an HA chimeric multiepitope nanoparticle vaccine
by: Yongqiang Zhao, et al.
Published: (2025-02-01)

Optimal control of vaccination dynamics during an influenza epidemic
by: Majid Jaberi-Douraki, et al.
Published: (2014-05-01)

Influenza Vaccination Rates, Perceptions, and Vaccine Hesitancy in K-12 Teachers and Staff
by: Kevin Cleveland, et al.
Published: (2025-02-01)

Rapid Verbal Persuasion to increase influenza vaccine uptake: protocol for a randomized hybrid type 2 effectiveness -implementation trial
by: Siyuan Liu, et al.
Published: (2025-02-01)

Epidemic Analysis and Mathematical Modelling of Influenza with Vaccination.
by: Musiime, Catherine
Published: (2024)

Epidemic Analysis and Mathematical Modelling of Influenza with Vaccination
by: Musiime, Catherine
Published: (2022)

Factors Affecting Influenza and Pneumococcal Vaccination Rates in Hemodialysis Patients: A Multicenter Study
by: Selen T, et al.
Published: (2025-01-01)

Seasonal Influenza Vaccination Uptake Among Australian Healthcare Professionals: An Archetype for Success
by: Caroline M. Hall, et al.
Published: (2025-01-01)

Optimal strategies of social distancing and vaccination against seasonal influenza
by: Eunha Shim
Published: (2013-07-01)

A note on the use of influenza vaccination strategies when supply is limited
by: Sunmi Lee, et al.
Published: (2010-12-01)

Assessing the impact of educational methods on influenza vaccine uptake and patient knowledge and attitudes: a randomised controlled trial
by: Pei Lin Hu, et al.
Published: (2023-02-01)

Are we serologically prepared against an avian influenza pandemic and could seasonal flu vaccines help us?
by: Iván Sanz-Muñoz, et al.
Published: (2025-02-01)

Comparative testing of vaccines based on viruses of genetic lineages G1 and Y280 for their potency against low pathogenic avian influenza H9N2
by: S. V. Frolov, et al.
Published: (2021-08-01)

Sociodemographic disparities in influenza vaccination among older adults in United States
by: Huan Tao, et al.
Published: (2025-02-01)

Prioritization of delayed vaccination for pandemic influenza
by: Eunha Shim
Published: (2010-12-01)

Optimal individual strategies for influenza vaccines with imperfect efficacy and durability of protection
by: Francesco Salvarani, et al.
Published: (2018-05-01)

Evaluation of humoral immune response and milk antibody transfer in calves and lactating cows vaccinated with inactivated H5 avian influenza vaccine
by: Mohamed Samy Abousenna, et al.
Published: (2025-02-01)

Critical assessment of uncertainty in economic evaluations on influenza vaccines for the elderly population in Spain
by: Raúl Ortiz-de-Lejarazu Leonardo, et al.
Published: (2025-02-01)

Relationship between influenza-related experience and current vaccination outcome
by: Yunwei Gai
Published: (2025-01-01)

Attitudes Toward General Vaccination Mediate the Association Between Influenza Vaccination History and Pneumococcal Vaccination Intention Among Older Adults in China
by: Siwen Huang, et al.
Published: (2024-12-01)

Evaluation of Influenza Vaccine Effectiveness from 2021 to 2024: A Guangdong-Based Test-Negative Case–Control Study
by: Liyan Zhu, et al.
Published: (2024-12-01)

The impact of vaccines and vaccinations: Challenges and opportunities for modelers
by: Roy Curtiss III
Published: (2010-12-01)

Peptide Antigen Modifications Influence the On-Target and Off-Target Antibody Response for an Influenza Subunit Vaccine
by: Megan C. Schulte, et al.
Published: (2025-01-01)

Evaluation of vaccination strategies during pandemic outbreaks
by: Christopher S. Bowman, et al.
Published: (2010-12-01)

Safety, reactogenicity, and immunogenicity of Ad26.COV2.S co-administered with a quadrivalent standard-dose or high-dose seasonal influenza vaccine: a non-inferiority randomised controlled trialResearch in context
by: Gabriela Tapia-Calle, et al.
Published: (2025-01-01)

Mucosal Immunization with an Influenza Vector Carrying SARS-CoV-2 N Protein Protects Naïve Mice and Prevents Disease Enhancement in Seropositive Th2-Prone Mice
by: Mariia V. Sergeeva, et al.
Published: (2024-12-01)

Adjuvant-free, self−assembling ferritin nanoparticle vaccine coupled with influenza virus hemagglutinin protein carrying M1 and PADRE epitopes elicits cross-protective immune responses
by: Yongqiang Zhao, et al.
Published: (2025-01-01)

Parental Attitudes, Motivators and Barriers Toward Children’s Vaccination in Poland: A Scoping Review
by: Krystyna Szalast, et al.
Published: (2025-01-01)

Immunogenicity of HIV-1 <i>Env</i> mRNA and <i>Env-Gag</i> VLP mRNA Vaccines in Mice
by: Qi Ma, et al.
Published: (2025-01-01)

SIRV fractional epidemic model of influenza with vaccine game theory and stability analysis
by: Qun Dai, et al.
Published: (2024-12-01)

Human papillomavirus vaccination hesitancy among young girls in Ethiopia: factors and barriers to uptake
by: Ashenafi Kibret Sendekie, et al.
Published: (2025-01-01)

Editorial: Building public confidence in innovative mRNA vaccines
by: Jia Hu, et al.
Published: (2025-01-01)

Advances in nucleic acid-based cancer vaccines
by: Hung-Chun Liao, et al.
Published: (2025-01-01)

What is a vaccine?
by: Melissa K. Jones, et al.
Published: (2022-06-01)